A site where you can find recommended contractors for non-clinical testing|effical " Non-Clinical CROs and Agencies " Absorption Systems

Absorption Systems

In addition to in-house testing, Absorption Systems coordinates outsourced toxicology and pharmacokinetic studies and other tests to optimal facilities by leveraging a global network of CROs (Contract Research Organizations). Here, we introduce Absorption Systems' features and disease models.

Features of Absorption Systems' Non-clinical Testing Contract Services

Access to a wide range of non-clinical studies and a flexible CRO network

By leveraging a network of numerous partner CROs, we offer access to a wide range of non-clinical studies, including toxicology, DMPK/ADME, safety pharmacology, disease models, and even the biodefense sector. Because our services are not limited to specific areas, we can provide consistent support from early drug discovery through late-stage development.Rapidly secure optimal testing resources according to the client's research content and development phase.The ability to do so is a major strength.

CRO Selection and Approval Application Support in Compliance with Regulatory Standards

Depending on the client's testing objectives and target market,Accurately match CROs with facilities and systems that comply with the standards of various regulatory authorities such as OECD GLP, FDA, and EMA.They also support the creation of regulatory dossiers, including IND applications, and propose study designs that meet requirements. They can build a consistent non-clinical strategy with the approval process in mind.

Selection of optimal facilities and cost optimization from a neutral standpoint

One of the features of Absorption Systems isFacility selection from a neutral position, independent of specific CROsThis allows us to select the most suitable CRO globally for each project, optimizing the balance between quality, cost, and schedule. It also enables us to reduce unnecessary costs while diversifying risks, thereby increasing the probability of project success. We achieve efficient and strategic non-clinical development.

Introduction to the Contract Companies Handled by Absorption Systems

Absorption Systems leverages a global network, not limited to specific CROs, to select the most suitable contract research organization for each project.

As an example, I can introduce a contract company like the following.

An example of a disease model held by Absorption Systems

Humanized Mouse Models

Absorption Systems collaborates with specialized CROs such as Biocytogen to provide access to humanized mouse models that replicate the human immune system. These models are useful for evaluating immune responses and the efficacy and safety of antibody drugs.

Tumor and Cancer Models

We can provide a variety of cancer models suitable for tumor development, progression, and efficacy evaluation. By utilizing transplantable and genetically modified models, we can accurately assess the effects of anti-cancer drugs and immunotherapies.

Non-clinical case studies of Absorption Systems

Can solve the challenges of a shortage of specialized resources and complex regulatory compliance.

There were no specific written examples of non-clinical studies.Solving the challenges of "lack of specialized resources" and "complex regulatory compliance" faced by pharmaceutical and biotechnology companies in non-clinical developmentWe will engage in strategic study design for New Drug Application (IND) filings, select optimal partners from a global pool of CROs (Contract Research Organizations), and delegate the overall monitoring of studies. We provide extensive expertise in toxicology, pharmacokinetics, and safety pharmacology to enhance the reliability of study data and ensure compliance with regulatory requirements. We offer comprehensive support to minimize the risks of development delays and technical issues, efficiently advancing projects within limited budgets and timeframes.

Absorption Systems company information

Address 436 Creamery Way, Suite 600, Exton, Pennsylvania 19341, USA
Tel +1-610-280-2000
Website https://abogenbio.com/
3 Recommended Contract Research Organizations for Non-Clinical Studies
— by Target goal and Expertise

In drug discovery, the quality and efficiency of non-clinical studies have a direct impact on clinical success rates, development costs, and overall length of time required in R&D. In recent years, there has been more demand for clinically relevant data, globally accepted reliability, and accurate early-stage screening. Thus, it is more important than ever to select the right CRO (Contract Research Organization) for strategic approach.
In this article, we highlight three CROs with proven technical capabilities, expertise, and long standing track records. These are our TOP 3 choices based on their capabilities and the specific target goals of the researchers for their non-clinical studies.

Pharmacology (Efficacy) Studies
Replicate unknown pathological models and
Discovery to clinically oriented drug evaluation
SMC Laboratories, Inc.
SMC Laboratories, Inc.
Reference: SMC Laboratories official website (https://www.smccro-lab.com/jp/)
  • SMC Laboratories has established a disease models using patented mouse technologies. The company has established proprietary pathological models—particularly in liver disease and fibrosis—and continues to expand their approach across a wide range of models in cancer, inflammation, and metabolic diseases.
  • From exploratory research to clinically oriented efficacy evaluation, SMC offers customized study designs, dosing strategies, and evaluation analysis tailored to each project. Their collaborative approachallows researchers to discuss and refine study plans together with SMC’s expert scientists.

  • With flexible small-scale study options and strong technical support, SMC Laboratories is an ideal partner for start-ups, biotech ventures, and academic institutions alike.
Safety Studies
Comprehensive Safety Evaluation for FIH Applications
labcorp
(Labcorp Drug Development)
labcorp
Reference: labcorp official website (https://jp.labcorp.com/)
  • labcorp provides a fully integrated GLP testing system aligned with international regulatory standards, including FDA, EMA, and PMDA requirements. All studies are conducted under ICH-compliant quality assurance, making it ready for data submission.
  • The company has extensive expertise in long-term toxicity studies such as Segment I–III reproductive and carcinogenicity studies, as well as 2-year chronic toxicity assessments.
  • labcorp’s comprehensive approach enables sponsors to efficiently outsource the entire preclinical package from toxicology, toxicokinetic (TK), and safety pharmacology study design to execution. This accelerates a path to First-in-Human (FIH) trials. For most of the global drug developers, this all-in-one service structure minimizes cost, risk, and expedite the time before advancing to clinical phase.
Pharmacokinetic (PK/PD) Studies
High-Precision Bioanalysis for Clinically Predictive PK/PD Evaluation
PhoenixBio
PhoenixBio
Source: PhoenixBio Official Website (https://phoenixbio.co.jp/)
  • PhoenixBio offers pharmacokinetic and hepatic metabolism studies using their proprietary PXB-mouse®, a humanized-liver chimeric mouse model. This platform enables the acquisition of data with high clinical correlation in ADME, drug–to-drug interaction studies, bridging the gap between preclinical and clinical stages.
  • With advanced LC-MS/MS-based bioanalysis, PhoenixBio provides aseamless workflow from plasma concentration measurement and metabolite identification to quantitative validation.

  • The company offersan integrated evaluation analysiscovering pharmacokinetics, hepatotoxicity, and safety with flexibility to accommodate complex modalities such as oligonucleotide and middle-molecule therapeutics. For compounds where hepatic metabolism is a development bottleneck—or where quantitative, reproducible exposure data are critical—PhoenixBio delivers unmatched analytical precision and consistency.

Consult Phoenix Bio for PK/PD analysis with a clinical focus
By region
list of animal models
Expertise & Track Record
3 Recommended CRO for Non-Clinical Studies